We are live on
!
Find out more
BA
Bridgewater Advisors Portfolio holdings
AUM
$1.83B
1-Year Est. Return
22.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+22.9%
3 Year Est. Return
+61.02%
5 Year Est. Return
+71.76%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$20M
(+20%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
12.51%
Top 10 Holdings %
Top 10 Hldgs %
40.12%
Holding
106
New
13
Increased
20
Reduced
31
Closed
8
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.5
quarters
Top 20 Avg Time Held
1.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$5.13M |
| 2 |
Invesco S&P 500 Pure Growth ETF
RPG
|
+$5.06M |
| 3 |
Colgate-Palmolive
CL
|
+$4.38M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.57M |
| 5 |
Cooper Companies
COO
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.93M |
| 2 |
AGN
Allergan Inc
AGN
|
+$1.73M |
| 3 |
Bunge Global
BG
|
+$1.32M |
| 4 |
Seaboard Corp
SEB
|
+$1.08M |
| 5 |
Citigroup
C
|
+$275K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.96% |
| 2 | Consumer Staples | 12.66% |
| 3 | Energy | 10.34% |
| 4 | Industrials | 8.2% |
| 5 | Healthcare | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
101
Citigroup
C
$217B
| – | – |
-5,779
| Closed | -$275K | – |
|
102
Gerdau
GGB
$10B
| – | – |
-13,210
| Closed | -$67K | – |
|
103
RH
RH
$2.21B
| – | – |
-2,795
| Closed | -$206K | – |
|
|
104
Seaboard Corp
SEB
$3.81B
| – | – |
-413
| Closed | -$1.08M | – |
|
|
FRTX
105
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| – | – |
-3
| Closed | -$14K | – |
|
|
AGN
106
DELISTED
Allergan Inc
AGN
| – | – |
-13,973
| Closed | -$1.73M | – |
|
Similar funds
KAM
WIC
SGI
RC
NSIM
SRIM
FI
Bridgewater Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Bridgewater Advisors held 106 positions worth $119M, up 20% from $99.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Bridgewater Advisors deployed $14.9M of net new capital in Q2 2014, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 32% a quarter earlier, followed by Consumer Staples and Energy.
On the sell side, the largest reduction was Pfizer, an estimated $1.93M trimmed.
- Bridgewater Advisors's largest Q2 2014 buy was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
- Bridgewater Advisors added most to Colgate-Palmolive in Q2 2014, an estimated $4.38M increase.
- Bridgewater Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.93M.
- Bridgewater Advisors fully exited Allergan Inc in Q2 2014, selling an estimated $1.73M.
- Bridgewater Advisors's ten largest holdings make up 40% of its $119M portfolio in Q2 2014.
- Bridgewater Advisors opened 13 new positions and closed 8 in Q2 2014.
- Bridgewater Advisors's portfolio value rose 20% quarter-over-quarter to $119M.
Based on Bridgewater Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.